Evidence map›Paper›PMID 41658267›Full record

ArticleJID innovations : skin science from molecules to population health2026

Association of immune checkpoint inhibitor-induced bullous pemphigoid with underlying cancer type: A lack of association with cancer tissue

Rachel C Chang, Henning Olbrich, Yulu F Wang, Haley Gainer, Nina Curkovic, Theresa L Walunas, Jessica Shiu, Parul Goyal, Adrian P Mansini, Ralf J Ludwig and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JID innovations : skin science from molecules to population health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rachel C ChangDepartment of Dermatology, Rush University Medical Center, Chicago, Illinois, USA.
Henning OlbrichDepartment of Dermatology, University of Lübeck, Lübeck, Germany.
Yulu F WangDepartment of Dermatology, Rush University Medical Center, Chicago, Illinois, USA.
Haley GainerDepartment of Dermatology, Rush University Medical Center, Chicago, Illinois, USA.
Nina CurkovicDepartment of Dermatology, University of Texas Southwestern, Dallas, Texas, USA.
Theresa L WalunasDivision of General Internal Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Jessica ShiuDepartment of Dermatology, University of California Irvine, Irvine, California, USA.
Parul GoyalDepartment of Dermatology, Rush University Medical Center, Chicago, Illinois, USA.
Adrian P MansiniDepartment of Dermatology, Rush University Medical Center, Chicago, Illinois, USA.
Ralf J LudwigDepartment of Dermatology, University of Lübeck, Lübeck, Germany.
Kyle T AmberDepartment of Dermatology, Rush University Medical Center, Chicago, Illinois, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bullous pemphigoid (BP) is an autoimmune blistering disease caused by autoantibodies to collagen type 17 (

Indexed as

Bullous pemphigoidCancer immunotherapyCOL17A1Immune checkpoint inhibitorsImmune-related adverse events

Identifiers

PMID41658267
PMCPMC12878624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.